Scientists have identified several genes associated with rapid lung function decline in former and current smokers that might help identify people who are most at risk of developing smoking-related conditions like chronic obstructive pulmonary disorder (COPD). These genes could also improve future clinical trials by helping to identify patients…
Enrollment is now concluded in a clinical trial evaluating the mechanism of action of RejuvenAir Metered Cryospray, an investigational treatment for chronic bronchitis, the most common form of chronic obstructive pulmonary disease (COPD). Chronic bronchitis is long-term inflammation of the airways, characterized by coughing and excessive mucus production.
Treatment with human mesenchymal stem cells (MSCs) effectively lessened hard-to-treat non-tuberculous mycobacteria (NTM) lung infection, and its associated weight loss, in a new mouse model susceptible to these infections, an early study reported. “The potential to use human mesenchymal stem cells to treat difficult lung infections is promising,” Anthony Atala,…
Note: This article was updated to include information from a Hopkins study published on May 5, 2021, of responses after a second vaccine dose was given to transplant patients. Long before COVID-19 changed the world, organ transplant recipients were wearing masks to shield themselves from airborne threats. Immunosuppressive medicines, which often…
NuvoAir has released a new mobile app for home use, called NuvoAir Cough, that can record and analyze coughing sounds made by patients with lung conditions, such as chronic obstructive pulmonary disease (COPD). The app is included in the NuvoAir Home platform, the company’s digital respiratory support system. Coughing…
Smiths Medical has launched a medical device designed to help people with chronic obstructive pulmonary disease (COPD) and other respiratory diseases to clear secretions from their lungs and breathe better. “The introduction of the acapella choice blue therapy system enhances the quality of life for those living with…
Verona Pharma has announced positive efficacy and safety results about using nebulized ensifentrine as an add-on therapy to tiotropium (Spiriva Respimat) for treating symptomatic chronic obstructive pulmonary disease (COPD). Results from the Phase 2b clinical trial (NCT03937479) show that ensifentrine treatment, combined with maintenance tiotropium, results in…
Scientists have found that a certain protein helps cells in the airways to clear away mucus, such as the mucus that builds up in chronic obstructive pulmonary disease (COPD). This discovery, they noted, suggests that boosting the activity of this protein, called adenine nucleotide translocase (ANT), could become a…
Certain risk factors may accurately predict in-hospital mortality, or death, in people with acute exacerbations of chronic obstructive pulmonary disease (COPD), a study revealed. These factors include the need for invasive mechanical ventilation (IMV), having chronic heart failure, and having a low number of immune white blood cells,…
Pulmatrix will regain full rights to its portfolio of narrow spectrum kinase inhibitor (NSKI) medications, including the investigational therapy PUR1800 to treat acute flare in chronic obstructive pulmonary disease (COPD) and other chronic diseases of the airways.
Get regular updates to your inbox.